Salivary duct carcinoma (SDC) is an uncommon, aggressive malignant neoplasm
histologically resembling high-grade mammary ductal carcinoma. SDC can arise de novo or …

Background Among salivary gland malignancies, the prognosis of salivary duct carcinoma
(SDC) is assumed to be the poorest. However, because of its low incidence, reliable survival …

Background: The efficacy and safety of human epidermal growth factor receptor 2 (HER2)-
targeted therapy and androgen deprivation therapy (ADT) for locally advanced or recurrent …

Identifying the specific functional regulator of integrin family molecules in cancer cells is
critical because they are directly involved in tumor invasion and metastasis. Here we report …

The molecular characteristics of therapeutically-relevant targets and their clinicopathological
implications in salivary duct carcinomas (SDCs) are poorly understood. We investigated the …

Purpose Sarcopenia, defined as a decrease in the skeletal muscle mass and its function, is
associated with a poor clinical outcome in several malignancies. We aimed to examine …

Purpose Persistent hypoparathyroidism (hypoPT) is a major complication of total
thyroidectomy. Nonetheless, previous reports may have underestimated the prevalence of …

Background It was reported that treatment outcomes of the salvage chemotherapy (SCT)
following nivolumab are fairly good compared with those of nivolumab itself. However …

Purpose The importance of nivolumab for recurrent or metastatic (R/M) head and neck
squamous cell carcinoma (HNSCC) is rapidly increasing. However, prognostic factors have …

Objective Salivary duct carcinoma (SDC) is a highly aggressive and uncommon tumor
arising not only de novo but also in pleomorphic adenoma. Androgen receptor (AR)-and …